Clinical Research Directory

Inclusion Criteria: * Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database * Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months. * Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group) * Patients who signed the informed consent * Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes) Exclusion Criteria: * Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin) * Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention * Female subjects who are pregnant * Patients who did not sign the informed consent